Trials / Completed
CompletedNCT01916928
The Use of Cell Free Fetal DNA in the Maternal Blood in the Evaluation of Intrauterine Fetal Demise and Miscarriage
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (actual)
- Sponsor
- Medstar Health Research Institute · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Women presenting to Washington Hospital Center with fetal loss would be offered participation in the study. The objective is to determine if ccffDNA obtained from maternal blood is present in the setting of missed abortion or fetal demise. The investigators primary hypothesis is that cell free fetal DNA will be present in maternal blood in the presence of a failed pregnancy.
Conditions
Timeline
- Start date
- 2013-05-01
- Primary completion
- 2014-01-01
- Completion
- 2014-12-01
- First posted
- 2013-08-06
- Last updated
- 2017-03-13
- Results posted
- 2015-02-02
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01916928. Inclusion in this directory is not an endorsement.